News articles about West Pharmaceutical Services (NYSE:WST) have trended somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. West Pharmaceutical Services earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave headlines about the medical instruments supplier an impact score of 46.3777535920626 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

A number of research firms recently commented on WST. Stephens began coverage on shares of West Pharmaceutical Services in a research note on Tuesday, October 3rd. They set an “equal weight” rating and a $99.00 price target for the company. Wells Fargo & Company lifted their price target on shares of West Pharmaceutical Services from $105.00 to $112.00 and gave the stock an “outperform” rating in a research note on Friday, October 27th. Jefferies Group raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and lifted their price target for the stock from $96.00 to $115.00 in a research note on Friday, September 15th. BidaskClub cut shares of West Pharmaceutical Services from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 3rd. Finally, Zacks Investment Research raised shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research note on Wednesday, September 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $106.00.

Shares of West Pharmaceutical Services (WST) traded down $0.82 on Friday, reaching $99.11. 288,935 shares of the company were exchanged, compared to its average volume of 363,647. West Pharmaceutical Services has a one year low of $77.97 and a one year high of $103.36. The company has a market cap of $7,154.27, a price-to-earnings ratio of 41.53, a price-to-earnings-growth ratio of 2.05 and a beta of 1.14. The company has a quick ratio of 1.87, a current ratio of 2.59 and a debt-to-equity ratio of 0.15.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings data on Thursday, October 26th. The medical instruments supplier reported $0.67 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.14. West Pharmaceutical Services had a net margin of 12.12% and a return on equity of 14.47%. The company had revenue of $398.20 million during the quarter, compared to analyst estimates of $386.02 million. During the same quarter last year, the business posted $0.53 EPS. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. equities analysts predict that West Pharmaceutical Services will post 2.76 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “West Pharmaceutical Services (WST) Earns Daily Media Sentiment Score of 0.19” was first published by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Insider Buying and Selling by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with's FREE daily email newsletter.